Detailed price information for Qualigen Therapeutics Inc (QLGN-Q) from The Globe and Mail including charting and trades.

Detailed price information for Qualigen Therapeutics Inc (QLGN-Q) from The Globe and Mail including charting and trades.

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between ...

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on developing platform treatments for adult and pediatric cancers with the potential for orphan ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the "Company") received two different communications from the staff of the Nasdaq Listing Qualifications ...

Each method presents an entry point for young Ugandans, depending on location, resource availability, and market access. With appropriate training and support, youth can participate across the full ...

This report provides a comprehensive look at the global market for G protein-coupled receptor (GPCR) targeting technologies.

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

If you are looking to buy fashion accessories like sunglasses, perfumes, and makeup products, you're at the right place.

Asda shoppers spot healthy sweet treat with 20g protein per serving Asda shoppers looking to add more protein to their diets are eager to track down a delicious sweet snack which costs just £1.17.

Q: I’m trying to improve my nutrition, but it’s not easy. Can you help me feel more motivated, please? — Jenny T., Evanston, Ill.